3Ambrosch A, Dierkes J, Lobmann R, et al. Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus. Diabetic Medicine, 2001,18(3) :185 - 192.
4Friedman EA. Advanced glycosylated end - products and hyperglycaemia in the pathogenesis of diabetic complications. Diabetes Care, 1999,22 ( Suppl 2):1365 - 1371.
5Schmidt AM, Yan SD, Yan SF, et al. The biology of the receptor for advanced glycation end products and its ligands.Biochim Biophys Acta,2000,1498(2 - 3) :99 - 111.
6Bucciarelli LG, Wendt T, Rong L, et al. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol Life Sci,2002,59(7) .1117 - 1128.
7Wendt T,Tanji N, Guo J,et al. Glucose,glycation and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy. J Am Soc Nephrol,2003,14:1383- 1395.
8Bierhaus A, Schiekofer S, Schwaninger M, et al. Diabetes - associated sustained activation of the transcription factor nuclear factor kappa B. Diabetes, 2001,50:2792 - 2808.
9Sakaguchi T, Sousa M, Yan SD, et al. Restenosis: central role of RAGE - dependent neointimal expansion. Circulation, 2001,104(Suppl) : Ⅱ - 522.
10Kislinger T, Tanji N, Wendt T, et al. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E- null mice. Arterioscler Thromb,2001,21:905 - 910.
